🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to learn about a new bowel preparation that us...
Status
Completed
Location
Multiple Locations
Start Date
2015-05
Trial ID
NCT02402270
Treatments Being Tested
Colonoscopy is the gold standard in bowel assessment when there is suspicio...
Status
Completed
Location
Hospital de Clinicas
Start Date
2023-02-10
Trial ID
NCT05726344
Treatments Being Tested
The purpose of this study is to determine whether patients with opioid indu...
Status
Completed
Location
Research Site
Start Date
2017-03-02
Trial ID
NCT03060512
Treatments Being Tested
This study is a Phase IIb, randomized, multicentre, parallel group, open-la...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-04-28
Trial ID
NCT02120352
Treatments Being Tested
Clostridium Difficile infections (CDIs) are treated initially with antibiot...
Status
Unknown
Location
London Health Sciences Centre
Start Date
2016-08
Trial ID
NCT02466698
Treatments Being Tested
The investigators propose to investigate Microbiota Transfer Therapy (MTT) ...
Status
Active Not Recruiting
Location
Arizona State University
Start Date
2019-11-15
Trial ID
NCT04182633
In previous studies at a university referral center the investigators demon...
Status
Terminated
Location
University of North Carolina at Chapel Hill
Start Date
2013-01
Trial ID
NCT01717456
The primary objective is to measure levels of selected PEG 3350 components ...
Status
Completed
Location
Children's Hospital of Philadelphia
Start Date
2022-09-30
Trial ID
NCT05424757
Treatments Being Tested
This randomized, parallel, multi-center, single-blind study is designed to ...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00425594
This study is a multicentre randomized parallel group phase IV study compar...
Status
Completed
Location
Centro di Riferimento Oncologico
Start Date
2018-10-31
Trial ID
NCT03742232
Treatments Being Tested